Andrographolide/Sodium Hydrogen Sulfite

穿心莲内酯/亚硫酸氢钠

Report date: 2023/02/26 21:49:51

Base Information

Drug NameAndrographolide/Sodium Hydrogen Sulfite
Drug Alias Name亚硫酸氢钠穿心莲内酯
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsTumor necrosis factor α inhibitorsInterleukin-1 beta inhibitors +[4] 
TargetsNuclear factor NF-kappa-B complexTumor necrosis factor αInterleukin-1 beta +[4] 
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AndrographolideSodium Hydrogen Sulfite
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A